Base Pair Biotechnologies Completes $3.2 Million Series A-3 Financing Round and Opens New Facility

November 28, 2017   10:40 AM Eastern Standard Time

PEARLAND, Texas–(Business Wire)–Base Pair Biotechnologies, Inc., The Aptamer Discovery CompanyTM, today announced the completion of its $3.2 Million Series A-3 financing round and the opening of its new 5,000 square foot laboratory and office facility in Pearland, TX, a Houston suburb.  Toronto-based Eventi Capital Partners Inc. and Base Pair Canada led the round, with participation from earlier investors Houston-based BioTex, Inc. and Ashok Gowda, BioTex’s President & CEO, one of Base Pair’s founders.  Read More …

 

Base Pair and Nexmos Create DNA Aptamers that Inhibit Vitamin C Oxidation

December 28, 2016   8:00 AM Eastern Standard Time

Pearland, Texas, U.S.A. and Seoul, South Korea – (PR Newswire) – Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.  These molecules stabilize vitamin C, enabling development of new cosmetics, nutraceuticals, beverages and therapeutic agents with longer shelf life and potentially greater efficacy.  Nexmos plans to launch the first product containing these molecules in the second half of 2017, as a component of an antioxidant beverage formulation, in collaboration with a major health beverage company.  Read More …